SG10201913572TA - Injectable slurries and methods of manufacturing and using the same - Google Patents

Injectable slurries and methods of manufacturing and using the same

Info

Publication number
SG10201913572TA
SG10201913572TA SG10201913572TA SG10201913572TA SG10201913572TA SG 10201913572T A SG10201913572T A SG 10201913572TA SG 10201913572T A SG10201913572T A SG 10201913572TA SG 10201913572T A SG10201913572T A SG 10201913572TA SG 10201913572T A SG10201913572T A SG 10201913572TA
Authority
SG
Singapore
Prior art keywords
manufacturing
methods
same
injectable slurries
slurries
Prior art date
Application number
SG10201913572TA
Other languages
English (en)
Inventor
Lilit Garibyan
Richard Anderson
William Farinelli
Emilia Javorsky
Original Assignee
Massachusetts Gen Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Gen Hospital filed Critical Massachusetts Gen Hospital
Publication of SG10201913572TA publication Critical patent/SG10201913572TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00434—Neural system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/02—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques
    • A61B2018/0293—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by cooling, e.g. cryogenic techniques using an instrument interstitially inserted into the body, e.g. needle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
    • A61F2007/0059—Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit
    • A61F2007/0063—Heating or cooling appliances for medical or therapeutic treatment of the human body with an open fluid circuit for cooling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Anesthesiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
SG10201913572TA 2014-08-28 2015-08-27 Injectable slurries and methods of manufacturing and using the same SG10201913572TA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462042979P 2014-08-28 2014-08-28
US201562121329P 2015-02-26 2015-02-26
US201562121472P 2015-02-26 2015-02-26

Publications (1)

Publication Number Publication Date
SG10201913572TA true SG10201913572TA (en) 2020-03-30

Family

ID=55400611

Family Applications (4)

Application Number Title Priority Date Filing Date
SG11201701505RA SG11201701505RA (en) 2014-08-28 2015-08-27 Injectable slurries and methods of manufacturing and using the same
SG11201701504WA SG11201701504WA (en) 2014-08-28 2015-08-27 Compositions and methods for treatment of neurological disorders
SG10201913564WA SG10201913564WA (en) 2014-08-28 2015-08-27 Compositions and methods for treatment of neurological disorders
SG10201913572TA SG10201913572TA (en) 2014-08-28 2015-08-27 Injectable slurries and methods of manufacturing and using the same

Family Applications Before (3)

Application Number Title Priority Date Filing Date
SG11201701505RA SG11201701505RA (en) 2014-08-28 2015-08-27 Injectable slurries and methods of manufacturing and using the same
SG11201701504WA SG11201701504WA (en) 2014-08-28 2015-08-27 Compositions and methods for treatment of neurological disorders
SG10201913564WA SG10201913564WA (en) 2014-08-28 2015-08-27 Compositions and methods for treatment of neurological disorders

Country Status (16)

Country Link
US (5) US20170274078A1 (ja)
EP (4) EP3185876B1 (ja)
JP (6) JP6707525B2 (ja)
KR (2) KR20170044199A (ja)
CN (4) CN113813222A (ja)
AU (4) AU2015308790B2 (ja)
BR (2) BR112017003111B1 (ja)
CA (2) CA2958769A1 (ja)
DK (2) DK3185876T3 (ja)
ES (1) ES2898097T3 (ja)
MX (3) MX2017002274A (ja)
PL (1) PL3185854T3 (ja)
PT (1) PT3185854T (ja)
SG (4) SG11201701505RA (ja)
WO (2) WO2016033380A1 (ja)
ZA (3) ZA201701048B (ja)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011100692A1 (en) 2010-02-15 2011-08-18 The General Hospital Corporation Methods and devices for selective disruption of visceral fat by controlled cooling
BR112013011944B1 (pt) 2010-11-16 2022-02-22 TVA Medical, Inc Sistema para formação de uma fistula
AU2012362524B2 (en) 2011-12-30 2018-12-13 Relievant Medsystems, Inc. Systems and methods for treating back pain
US10588691B2 (en) 2012-09-12 2020-03-17 Relievant Medsystems, Inc. Radiofrequency ablation of tissue within a vertebral body
JP2015532152A (ja) 2012-10-11 2015-11-09 ティーブイエー メディカル， インコーポレイテッド フィステル形成のための装置および方法
IL238516B (en) 2012-11-05 2022-08-01 Relievant Medsystems Inc System and methods for creating curved pathways through bone and regulating the nerves within the bone
ES2743505T3 (es) 2013-03-14 2020-02-19 Tva Medical Inc Dispositivos para la formación de fístulas
US9724151B2 (en) 2013-08-08 2017-08-08 Relievant Medsystems, Inc. Modulating nerves within bone using bone fasteners
EA201691073A1 (ru) 2013-12-05 2016-12-30 РФЕМБ ХОЛДИНГС, ЭлЭлСи Иммунотерапия рака с помощью радиочастотного электрического пробоя мембраны (rf-emb)
WO2015138998A1 (en) 2014-03-14 2015-09-17 Tva Medical, Inc. Fistula formation devices and methods therefor
WO2016033374A1 (en) 2014-08-27 2016-03-03 Tva Medical, Inc. Cryolipopysis devices and methods therefor
ES2898097T3 (es) 2014-08-28 2022-03-03 Massachusetts Gen Hospital Suspensiones inyectables y métodos para fabricarlas y usarlas
US11471401B2 (en) 2014-08-28 2022-10-18 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
US11504322B2 (en) 2014-08-28 2022-11-22 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
WO2016053741A1 (en) 2014-10-01 2016-04-07 Cryosa, Llc Apparatus and methods for treatment of obstructive sleep apnea utilizing cryolysis of adipose tissues
US10603040B1 (en) 2015-02-09 2020-03-31 Tva Medical, Inc. Methods for treating hypertension and reducing blood pressure with formation of fistula
US11161156B2 (en) * 2015-10-27 2021-11-02 Hamilton Sundstrand Corporation Powder monitoring
CA3011460A1 (en) 2016-01-15 2017-07-20 Rfemb Holdings, Llc Immunologic treatment of cancer
EP4218642A3 (en) 2016-01-15 2023-08-09 TVA Medical, Inc. Devices and methods for forming a fistula
WO2017124059A1 (en) 2016-01-15 2017-07-20 Tva Medical, Inc. Devices and methods for advancing a wire
US10874422B2 (en) 2016-01-15 2020-12-29 Tva Medical, Inc. Systems and methods for increasing blood flow
JP2019506248A (ja) 2016-02-26 2019-03-07 ザ ジェネラル ホスピタル コーポレイション 医療用氷スラリーの生成と送達システム及び方法
WO2018057095A1 (en) 2016-09-25 2018-03-29 Tva Medical, Inc. Vascular stent devices and methods
EP3534852B1 (en) * 2016-11-02 2022-02-02 Miraki Innovation Think Tank LLC Devices for slurry generation
US11324673B2 (en) * 2016-11-18 2022-05-10 Miraki Innovation Think Tank Llc Cosmetic appearance of skin
BR112019018191A2 (pt) * 2017-03-01 2020-06-23 Miraki Innovation Think Tank Llc Crioterapias
EP3606456A4 (en) 2017-04-05 2021-01-13 Miraki Innovation Think Tank LLC COLD THICK SUSPENSION CONTAINMENT
CA3059294A1 (en) 2017-04-05 2018-10-11 Miraki Innovation Think Tank Llc Point of delivery cold slurry generation
US10500342B2 (en) 2017-08-21 2019-12-10 Miraki Innovation Think Tank Llc Cold slurry syringe
US20210068643A1 (en) * 2017-12-11 2021-03-11 Saban Ventures Pty Limited Suspension cleaning
SG11202103368XA (en) * 2018-10-04 2021-04-29 Miraki Innovation Think Tank Llc Methods of treating subcutaneous fat layers
MX2021003824A (es) * 2018-10-04 2021-09-08 Miraki Innovation Think Tank Llc Composiciones de suspension y solucion.
AU2019357601A1 (en) * 2018-10-10 2021-05-13 Miraki Innovation Think Tank Llc Systems and methods for generating slurry
US20210346192A1 (en) * 2018-10-10 2021-11-11 Miraki Innovation Think Tank Llc Systems and methods of generating cold slurry for injection
JP2022502468A (ja) * 2018-10-12 2022-01-11 ミラキ イノベーション シンク タンク エルエルシー 脂肪減少用低温溶液
CN109800472B (zh) * 2018-12-26 2022-09-27 哈尔滨工程大学 一种冰桨接触过程中桨叶表面瞬时冰载压力分布计算方法
US11576812B2 (en) 2019-04-25 2023-02-14 Carlos Wambier Methods for reducing body fat in a subject
EP4003295A1 (en) 2019-07-24 2022-06-01 The General Hospital Corporation Methods of creating a substance with different freezing points by encapsulation
EP4027912A4 (en) 2019-09-12 2023-08-16 Relievant Medsystems, Inc. TISSUE MODULATION SYSTEMS AND METHODS
EP4034019A1 (en) 2019-09-26 2022-08-03 Miraki Innovation Think Tank LLC Miniaturized intra-body controllable medical device
BR112022012482A2 (pt) * 2019-12-24 2022-11-22 Miraki Innovation Think Tank Llc Composição, e, métodos para tratamento de tecido adiposo subcutâneo, para criar um plano de tratamento para um sujeito e para gerar uma composição
WO2021133720A1 (en) * 2019-12-26 2021-07-01 Miraki Innovative Think Tank Llc Treatment of obstructive sleep apnea
US20230028322A1 (en) * 2019-12-31 2023-01-26 Miraki Innovation Think Tank Llc Cold solution for inducing therapeutic hypothermia
JP2023511404A (ja) 2020-01-23 2023-03-17 ザ ジェネラル ホスピタル コーポレイション 神経系への増強された薬物送達の方法
CA3173472A1 (en) 2020-03-27 2021-09-30 James Anthony Stefater, Iii Methods of alleviating symptoms of ocular surface discomfort using medical ice slurry
CA3193608A1 (en) 2020-07-10 2022-01-13 C Change Surgical Llc Injectable slush feed supply
US20230285350A1 (en) * 2020-07-15 2023-09-14 Lyotip, Inc. Formulations for tetracaine and lidocaine
US20220071900A1 (en) * 2020-09-08 2022-03-10 Brixton Biosciences, Inc. Systems and methods for preparing and transporting an injectable slurry
US20220087250A1 (en) * 2020-09-24 2022-03-24 Everest Medical Innovation GmbH Cryoprotective Compositions and Methods for Protection of a Surgical Site During Cryosurgery
US12082876B1 (en) 2020-09-28 2024-09-10 Relievant Medsystems, Inc. Introducer drill
JP2024505335A (ja) 2020-12-22 2024-02-06 リリーバント メドシステムズ、インコーポレイテッド 脊椎神経調節の候補の予測
US11241330B1 (en) 2021-04-02 2022-02-08 Brixton Biosciences, Inc. Apparatus for creation of injectable slurry
US11490925B1 (en) 2021-06-09 2022-11-08 Mohammed A. Alsufyani Combination ultrasound transducer and fat injecting cannula
JP2024522208A (ja) * 2021-06-11 2024-06-11 ブリクストン バイオサイエンシズ インコーポレイテッド リポソームエマルジョンを使用してスラリーを作製する方法
US20240342210A1 (en) * 2021-10-14 2024-10-17 The General Hospital Corporation Compositions and methods for treatment of obstructive sleep apnea
KR20240148356A (ko) * 2022-02-07 2024-10-11 마틴 제이. 모스코비츠 극저온 수술 장치와 재료 및 그 사용 방법

Family Cites Families (137)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1256372A (en) 1985-04-11 1989-06-27 Koichiro Miyazima Process for producing liposome composition
US5143063A (en) 1988-02-09 1992-09-01 Fellner Donald G Method of removing adipose tissue from the body
JP2512095B2 (ja) * 1988-08-12 1996-07-03 株式会社日立製作所 冷熱発生方法
JP2792702B2 (ja) 1988-10-05 1998-09-03 ネクスター・フアーマシユーテイカルズ・インコーポレイテツド 乾燥時に改善された安定性を示すリポソームの調製方法
US5005364A (en) 1990-02-07 1991-04-09 Nelson William R Apparatus for and method of making and delivering slush ice
EP0593624B1 (en) 1991-07-05 1997-04-23 Nycomed Imaging As Improvements in or relating to contrast agents
US5507790A (en) 1994-03-21 1996-04-16 Weiss; William V. Method of non-invasive reduction of human site-specific subcutaneous fat tissue deposits by accelerated lipolysis metabolism
US5769879A (en) 1995-06-07 1998-06-23 Medical Contouring Corporation Microwave applicator and method of operation
US6126657A (en) 1996-02-23 2000-10-03 Somnus Medical Technologies, Inc. Apparatus for treatment of air way obstructions
US6464697B1 (en) 1998-02-19 2002-10-15 Curon Medical, Inc. Stomach and adjoining tissue regions in the esophagus
US6467953B1 (en) 1999-03-30 2002-10-22 Medical Solutions, Inc. Method and apparatus for monitoring temperature of intravenously delivered fluids and other medical items
US7892229B2 (en) 2003-01-18 2011-02-22 Tsunami Medtech, Llc Medical instruments and techniques for treating pulmonary disorders
US6126684A (en) 1998-04-21 2000-10-03 The Regents Of The University Of California Indwelling heat exchange catheter and method of using same
US6546932B1 (en) 1999-04-05 2003-04-15 Cryocath Technologies Inc. Cryogenic method and apparatus for promoting angiogenesis
JP3111219B1 (ja) * 1999-05-25 2000-11-20 工業技術院長 ポリビニルアルコールを利用した冷熱輸送方法及び装置
PT1196144E (pt) 1999-07-16 2004-12-31 Alza Corp Composicao de liposomas com resistencia ao dano da congelacao/descongelacao
US6596333B1 (en) 1999-07-21 2003-07-22 Nestec S.A. Process for producing aerated frozen products
US7422601B2 (en) * 1999-08-02 2008-09-09 University Of Chicago Office Of Technology Transfer Method for inducing hypothermia
US6413444B1 (en) 1999-08-02 2002-07-02 The University Of Chicago Methods and apparatus for producing phase change ice particulate saline slurries
US6962601B2 (en) 1999-08-02 2005-11-08 University Of Chicago Office Of Technology Transfer Method for inducing hypothermia
US6244052B1 (en) * 1999-08-02 2001-06-12 The University Of Chicago Method and apparatus for producing phase change ice particulate perfluorocarbon slurries
US6495164B1 (en) 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
US7306591B2 (en) 2000-10-02 2007-12-11 Novasys Medical, Inc. Apparatus and methods for treating female urinary incontinence
US7255865B2 (en) * 2000-12-05 2007-08-14 Allergan, Inc. Methods of administering botulinum toxin
US7897141B2 (en) 2002-04-01 2011-03-01 Drexel University Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof
US20030032996A1 (en) * 2001-08-08 2003-02-13 Hallman Arlan Jay Cryogenic massage tube and compress
US6709431B2 (en) 2001-12-18 2004-03-23 Scimed Life Systems, Inc. Cryo-temperature monitoring
IL163689A0 (en) * 2002-02-26 2005-12-18 Astrazeneca Ab Novel crystalline forms of the anti-cancer compound zd1839
US8840608B2 (en) 2002-03-15 2014-09-23 The General Hospital Corporation Methods and devices for selective disruption of fatty tissue by controlled cooling
CN110522505B (zh) 2002-03-15 2023-04-25 总医院公司 通过受控冷却对脂肪组织进行选择性破坏的系统
US6858025B2 (en) 2002-08-06 2005-02-22 Medically Advanced Designs, Llc Cryo-surgical apparatus and method of use
US7211104B2 (en) 2002-10-08 2007-05-01 Vital Wear, Inc. Contrast therapy system and method
US7083612B2 (en) 2003-01-15 2006-08-01 Cryodynamics, Llc Cryotherapy system
US20040258760A1 (en) 2003-03-20 2004-12-23 Wheatley Margaret A. Isolated nanocapsule populations and surfactant-stabilized microcapsules and nanocapsules for diagnostic imaging and drug delivery and methods for their production
WO2004088233A2 (en) 2003-03-26 2004-10-14 Regents Of The University Of Minnesota Thermal surgical procedures and compositions
US20060161232A1 (en) 2005-01-18 2006-07-20 Kasza, Oras and Son to The University of Chicago Phase-change particulate ice slurry coolant medical delivery tubing and insertion devices
US7850683B2 (en) 2005-05-20 2010-12-14 Myoscience, Inc. Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat)
US7713266B2 (en) 2005-05-20 2010-05-11 Myoscience, Inc. Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat)
WO2006127897A2 (en) 2005-05-24 2006-11-30 Uab Research Foundation Surgical delivery devices and methods
US7389653B2 (en) * 2005-09-15 2008-06-24 The University Of Chicago Medical ice slurry production device
US20070093697A1 (en) 2005-10-21 2007-04-26 Theranova, Llc Method and apparatus for detection of right to left shunting in the cardiopulmonary vasculature
US7854754B2 (en) 2006-02-22 2010-12-21 Zeltiq Aesthetics, Inc. Cooling device for removing heat from subcutaneous lipid-rich cells
GB0615287D0 (en) 2006-08-01 2006-09-06 Ares Trading Sa Integral membrane protein
US8192474B2 (en) 2006-09-26 2012-06-05 Zeltiq Aesthetics, Inc. Tissue treatment methods
JP2010508130A (ja) 2006-10-31 2010-03-18 ゼルティック エステティックス インコーポレイテッド 皮下高脂質細胞または皮下高脂質組織を冷却する方法およびその装置
US9254162B2 (en) 2006-12-21 2016-02-09 Myoscience, Inc. Dermal and transdermal cryogenic microprobe systems
US20080247957A1 (en) 2007-02-16 2008-10-09 Drexel University Advanced drug delivery strategy and platform for minimally-invasive treatment of liver cancer
WO2008150871A1 (en) 2007-05-30 2008-12-11 Critical Care Innovations, Inc. Process and device for selectively treating interstitial tissue
US20090028797A1 (en) 2007-06-14 2009-01-29 Drexel University Novel polymeric ultrasound contrast agent and methods of making thereof
AU2008275158A1 (en) 2007-07-09 2009-01-15 Velomedix, Inc Hypothermia devices and methods
US8523927B2 (en) 2007-07-13 2013-09-03 Zeltiq Aesthetics, Inc. System for treating lipid-rich regions
AU2008309520A1 (en) 2007-10-12 2009-04-16 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Method for opening tight junctions
WO2009065061A1 (en) 2007-11-14 2009-05-22 Myoscience, Inc. Pain management using cryogenic remodeling
US8563515B2 (en) 2007-11-19 2013-10-22 The Regents Of The University Of Colorado, A Body Corporate Tight junction protein modulators and uses thereof
US20090234325A1 (en) 2008-03-17 2009-09-17 Allan Rozenberg Methods and devices for non-invasive cerebral and systemic cooling
AU2009251688A1 (en) 2008-04-01 2009-12-03 The General Hospital Corporation Method and apparatus for cooling biological tissue
US8505315B2 (en) * 2008-04-15 2013-08-13 Uchicago Argonne, Llc Enhanced integrated operation blender based sterile medical ice slurry production device
US7874167B2 (en) 2008-06-06 2011-01-25 C Change Surgical Llc Method and apparatus for producing slush for surgical use
US20100036295A1 (en) 2008-08-08 2010-02-11 Palomar Medical Technologies, Inc. Method and apparatus for fractional deformation and treatment of cutaneous and subcutaneous tissue
US9060931B2 (en) 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for delivery of frozen particle adhesives
US8256233B2 (en) * 2008-10-31 2012-09-04 The Invention Science Fund I, Llc Systems, devices, and methods for making or administering frozen particles
US8603073B2 (en) 2008-12-17 2013-12-10 Zeltiq Aesthetics, Inc. Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells
WO2010083281A1 (en) 2009-01-15 2010-07-22 Boston Scientific Scimed, Inc. Controlling depth of cryoablation
US8608696B1 (en) 2009-02-24 2013-12-17 North Carolina State University Rapid fluid cooling devices and methods for cooling fluids
US20110009748A1 (en) 2009-06-11 2011-01-13 Galil Medical Ltd. Transperineal prostate biopsy system and methods
US20130011332A1 (en) 2009-09-15 2013-01-10 Searete Llc, Frozen Compositions and Methods for Piercing a Substrate
US20140200511A1 (en) * 2009-10-30 2014-07-17 Searete Llc Systems, devices, and methods for making or administering frozen particles
WO2011100692A1 (en) 2010-02-15 2011-08-18 The General Hospital Corporation Methods and devices for selective disruption of visceral fat by controlled cooling
CA2806892A1 (en) 2010-08-26 2012-03-01 Cryomedix, Llc Cryoablation balloon catheter and related method
US9095320B2 (en) 2010-09-27 2015-08-04 CyroMedix, LLC Cryo-induced renal neuromodulation devices and methods
US9060754B2 (en) 2010-10-26 2015-06-23 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation cryotherapeutic devices and associated systems and methods
US20120130458A1 (en) 2010-10-26 2012-05-24 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation cryotherapeutic devices and associated systems and methods
CA2820731A1 (en) 2010-12-13 2012-06-21 Myoscience, Inc. Method for reducing hyperdynamic facial wrinkles
GB2485864B (en) 2011-07-14 2013-05-29 Ide Technologies Ltd Vacuum ice maker (vim) with an integrated water vapor depostion process
ES2759611T3 (es) 2011-02-01 2020-05-11 Channel Medsystems Inc Aparato para el tratamiento criogénico de una cavidad o luz del cuerpo
SG10201607576PA (en) 2011-06-14 2016-11-29 Aerin Medical Inc Devices for treating nasal airways
EP2561886A1 (en) 2011-08-23 2013-02-27 Forschungsverbund Berlin e.V. Peptide adjuvant for improved peripheral analgesia
KR102113753B1 (ko) 2011-10-21 2020-05-21 셀라토 파마슈티칼즈, 인코포레이티드 동결건조된 리포좀
US9974684B2 (en) 2011-11-16 2018-05-22 The General Hospital Corporation Method and apparatus for cryogenic treatment of skin tissue
CA2860893A1 (en) 2012-01-13 2013-07-18 Myoscience, Inc. Skin protection for subdermal cryogenic remodeling for cosmetic and other treatments
EP2854681A4 (en) 2012-06-01 2016-02-17 Cibiem Inc PERCUTANEOUS METHODS AND DEVICES FOR CAROTIDE BODY ABLATION
JP6168644B2 (ja) 2012-07-12 2017-07-26 国立大学法人弘前大学 氷スラリー製造装置および氷スラリー製造方法
US9844460B2 (en) 2013-03-14 2017-12-19 Zeltiq Aesthetics, Inc. Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same
US9023023B2 (en) 2013-03-15 2015-05-05 Warsaw Orthopedic, Inc. Nerve and soft tissue ablation device
US9295512B2 (en) 2013-03-15 2016-03-29 Myoscience, Inc. Methods and devices for pain management
US20140350536A1 (en) 2013-03-15 2014-11-27 Myoscience, Inc. Cryogenic Blunt Dissection Methods and Devices
US9023022B2 (en) 2013-03-15 2015-05-05 Warsaw Orthopedic, Inc. Nerve and soft tissue ablation device having release instrument
US9033966B2 (en) 2013-03-15 2015-05-19 Warsaw Orthopedic, Inc. Nerve and soft tissue ablation device
US9610112B2 (en) 2013-03-15 2017-04-04 Myoscience, Inc. Cryogenic enhancement of joint function, alleviation of joint stiffness and/or alleviation of pain associated with osteoarthritis
US9131975B2 (en) 2013-03-15 2015-09-15 Warsaw Orthopedic, Inc. Nerve and soft tissue ablation device
CN105792875B (zh) 2013-08-05 2019-05-31 吴粤 一个制备和输送用于低温疗法的无气泡医用冰浆的方法和仪器
US9687288B2 (en) 2013-09-30 2017-06-27 Arrinex, Inc. Apparatus and methods for treating rhinitis
US10660688B2 (en) 2014-05-12 2020-05-26 Gary Kalser Cryotherapy device with cryoprotection and methods for performing cryotherapy with cryoprotection
US9763743B2 (en) 2014-07-25 2017-09-19 Arrinex, Inc. Apparatus and method for treating rhinitis
WO2016033374A1 (en) 2014-08-27 2016-03-03 Tva Medical, Inc. Cryolipopysis devices and methods therefor
US11504322B2 (en) 2014-08-28 2022-11-22 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
ES2898097T3 (es) 2014-08-28 2022-03-03 Massachusetts Gen Hospital Suspensiones inyectables y métodos para fabricarlas y usarlas
US11471401B2 (en) 2014-08-28 2022-10-18 The General Hospital Corporation Injectable slurries and methods of manufacturing the same
US9549843B2 (en) 2014-11-30 2017-01-24 C° Change Surgical Llc Production of well-mixed surgical slush
CN204468406U (zh) 2015-02-05 2015-07-15 张淑华 一种新型便携式冷敷装置
WO2016145452A1 (en) 2015-03-12 2016-09-15 Myoscience, Inc. Methods and systems for preventing neuroma formations
US20160317346A1 (en) 2015-04-28 2016-11-03 Zeltiq Aesthetics, Inc. Systems and methods for monitoring cooling of skin and tissue to identify freeze events
EP3399950A1 (en) 2016-01-07 2018-11-14 Zeltiq Aesthetics, Inc. Temperature-dependent adhesion between applicator and skin during cooling of tissue
JP2019506248A (ja) 2016-02-26 2019-03-07 ザ ジェネラル ホスピタル コーポレイション 医療用氷スラリーの生成と送達システム及び方法
CN105640642B (zh) 2016-04-07 2018-01-12 上海导向医疗系统有限公司 带扩张球囊的内冷却微波消融针
US11382790B2 (en) 2016-05-10 2022-07-12 Zeltiq Aesthetics, Inc. Skin freezing systems for treating acne and skin conditions
DE102016115387B3 (de) 2016-08-18 2018-02-01 Cardiolectra GmbH Medizinisches Gerät zur Denervierung renaler perivaskulärer Nerven
US20190183558A1 (en) 2016-08-30 2019-06-20 The General Hospital Corporation Cryotherapy and cryoablation systems and methods for treatment of tissue
EP3534852B1 (en) 2016-11-02 2022-02-02 Miraki Innovation Think Tank LLC Devices for slurry generation
KR101905830B1 (ko) 2016-11-15 2018-10-08 울산과학기술원 국부 냉각 마취 장치, 국부 냉각 마취 장치의 제어 방법 및 국부 냉각 마취 장치의 냉각 온도 조절기
US11324673B2 (en) 2016-11-18 2022-05-10 Miraki Innovation Think Tank Llc Cosmetic appearance of skin
EP4218637B8 (en) 2017-02-04 2024-10-02 Vessi Medical Ltd. Cryotherapy device flow control
US9980076B1 (en) 2017-02-21 2018-05-22 At&T Intellectual Property I, L.P. Audio adjustment and profile system
BR112019018191A2 (pt) 2017-03-01 2020-06-23 Miraki Innovation Think Tank Llc Crioterapias
WO2018175111A1 (en) 2017-03-21 2018-09-27 Zeltiq Aesthetics, Inc. Use of saccharides for cryoprotection and related technology
CA3059294A1 (en) 2017-04-05 2018-10-11 Miraki Innovation Think Tank Llc Point of delivery cold slurry generation
EP3606456A4 (en) 2017-04-05 2021-01-13 Miraki Innovation Think Tank LLC COLD THICK SUSPENSION CONTAINMENT
US10500342B2 (en) 2017-08-21 2019-12-10 Miraki Innovation Think Tank Llc Cold slurry syringe
US11523855B2 (en) 2018-09-28 2022-12-13 Team Neuro LLC Spinal pain management system and method
MX2021003824A (es) 2018-10-04 2021-09-08 Miraki Innovation Think Tank Llc Composiciones de suspension y solucion.
SG11202103368XA (en) 2018-10-04 2021-04-29 Miraki Innovation Think Tank Llc Methods of treating subcutaneous fat layers
US20210346192A1 (en) 2018-10-10 2021-11-11 Miraki Innovation Think Tank Llc Systems and methods of generating cold slurry for injection
AU2019357601A1 (en) 2018-10-10 2021-05-13 Miraki Innovation Think Tank Llc Systems and methods for generating slurry
JP2022502468A (ja) 2018-10-12 2022-01-11 ミラキ イノベーション シンク タンク エルエルシー 脂肪減少用低温溶液
EP4003295A1 (en) 2019-07-24 2022-06-01 The General Hospital Corporation Methods of creating a substance with different freezing points by encapsulation
US12121281B2 (en) 2019-08-07 2024-10-22 Christopher M. Shaari Systems and methods for cryogenic treatment of headache
US20220313484A1 (en) 2019-09-17 2022-10-06 Arrinex, Inc. Apparatus and Methods for Improved Nasal Cavity Treatments
BR112022012482A2 (pt) 2019-12-24 2022-11-22 Miraki Innovation Think Tank Llc Composição, e, métodos para tratamento de tecido adiposo subcutâneo, para criar um plano de tratamento para um sujeito e para gerar uma composição
WO2021133720A1 (en) 2019-12-26 2021-07-01 Miraki Innovative Think Tank Llc Treatment of obstructive sleep apnea
JP2023511404A (ja) 2020-01-23 2023-03-17 ザ ジェネラル ホスピタル コーポレイション 神経系への増強された薬物送達の方法
AU2021224877A1 (en) 2020-02-19 2022-08-11 Cryosa, Inc. Systems and methods for treatment of obstructive sleep apnea
CA3173472A1 (en) 2020-03-27 2021-09-30 James Anthony Stefater, Iii Methods of alleviating symptoms of ocular surface discomfort using medical ice slurry
US20210330927A1 (en) 2020-04-27 2021-10-28 Black Cat Medical Llc Method of performing cryoneurolysis
US20220071900A1 (en) 2020-09-08 2022-03-10 Brixton Biosciences, Inc. Systems and methods for preparing and transporting an injectable slurry
US20220087250A1 (en) 2020-09-24 2022-03-24 Everest Medical Innovation GmbH Cryoprotective Compositions and Methods for Protection of a Surgical Site During Cryosurgery
US20220211923A1 (en) 2020-09-24 2022-07-07 Everest Medical Innovation GmbH Cryoprotective Compositions, Surgical Kits, and Methods for Protection of a Surgical Site During Cryosurgery
US20220409428A1 (en) 2021-06-23 2022-12-29 Black Cat Medical Llc Method of performing cryoneurolysis

Also Published As

Publication number Publication date
CN106794138B (zh) 2021-10-01
US20210244817A1 (en) 2021-08-12
US11826427B2 (en) 2023-11-28
JP7201727B2 (ja) 2023-01-10
CA2958769A1 (en) 2016-03-03
JP6858698B2 (ja) 2021-04-21
US11938188B2 (en) 2024-03-26
DK3185854T3 (da) 2021-12-20
EP3185876A1 (en) 2017-07-05
EP3185876B1 (en) 2022-08-10
ZA201901279B (en) 2021-08-25
SG11201701505RA (en) 2017-03-30
WO2016033384A1 (en) 2016-03-03
JP2017526684A (ja) 2017-09-14
ZA201701080B (en) 2019-05-29
MX2017002274A (es) 2017-05-22
JP2021098748A (ja) 2021-07-01
EP4176885A1 (en) 2023-05-10
KR20170044199A (ko) 2017-04-24
US20240042034A1 (en) 2024-02-08
WO2016033380A1 (en) 2016-03-03
DK3185876T3 (da) 2022-10-31
AU2021200481A1 (en) 2021-02-25
KR20170045330A (ko) 2017-04-26
EP3185854A1 (en) 2017-07-05
CN107106481A (zh) 2017-08-29
CN106794138A (zh) 2017-05-31
ES2898097T3 (es) 2022-03-03
AU2015308790A1 (en) 2017-03-02
JP6707525B2 (ja) 2020-06-10
BR112017003143B1 (pt) 2023-12-05
JP2023060133A (ja) 2023-04-27
CA2958768C (en) 2023-08-29
JP2021152055A (ja) 2021-09-30
CN117064838A (zh) 2023-11-17
AU2021200481B2 (en) 2023-05-11
EP3185854B1 (en) 2021-10-06
US20210236639A1 (en) 2021-08-05
US20170274011A1 (en) 2017-09-28
BR112017003111B1 (pt) 2021-10-13
MX2021007621A (es) 2021-08-11
CN113813222A (zh) 2021-12-21
SG10201913564WA (en) 2020-03-30
EP3185854A4 (en) 2018-07-25
AU2015308794A1 (en) 2017-03-02
JP2020143113A (ja) 2020-09-10
US11964017B2 (en) 2024-04-23
JP7240447B2 (ja) 2023-03-15
ZA201701048B (en) 2023-12-20
PL3185854T3 (pl) 2022-01-31
PT3185854T (pt) 2021-12-03
KR102507789B1 (ko) 2023-03-07
EP3185876A4 (en) 2018-04-18
AU2015308790B2 (en) 2020-12-03
CA2958768A1 (en) 2016-03-03
MX2017002271A (es) 2017-05-22
BR112017003143A2 (pt) 2017-11-28
AU2023214304A1 (en) 2023-08-31
BR112017003111A2 (pt) 2017-12-05
EP3988105A1 (en) 2022-04-27
JP2017529336A (ja) 2017-10-05
US20170274078A1 (en) 2017-09-28
JP6903792B2 (ja) 2021-07-14
SG11201701504WA (en) 2017-03-30

Similar Documents

Publication Publication Date Title
SG11201701505RA (en) Injectable slurries and methods of manufacturing and using the same
HRP20192145T1 (hr) Pripravci nosača-antitijela i metode pripreme i uporabe istih
HK1232140A1 (zh) 微類器官以及製造和使用它們的方法
IL252216B (en) Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines
HK1231471A1 (zh) -雜芳氧基-和 芳氧基-喹啉- -甲酰胺及其用途
PL3215147T3 (pl) Związki norketaminy osłabiającej działanie układu nerwowego i sposoby
GB201402508D0 (en) Semiconductor modification process and structures
HK1208435A1 (en) Cement and manufacturing method thereof
GB201519128D0 (en) Solid forms and methods of preparing the same
SG11201704473WA (en) New methods and uses
HK1243342A1 (zh) 化合物和方法
PL3160322T3 (pl) Zmywarka i sposób obsługi zmywarki
GB201517786D0 (en) Methods and materials
PL3113774T3 (pl) Kompozycje grapiprantu i sposoby ich zastosowania
PL3234386T3 (pl) Element ślizgowy i sposób jego wytwarzania
GB201408091D0 (en) Methods and uses
GB201404364D0 (en) Construction material and method of manufacturing the same
ZA201500405B (en) Drumstick and method of manufacturing the same
PT2923578T (pt) Método para a produção de um produto alimentar
GB201402924D0 (en) The theory of instantransmission
GB201416086D0 (en) Methods and uses
GB201416073D0 (en) Methods and uses
GB201404728D0 (en) Disc-over incorporating disc-heads and disc-earning